PMID: 16526536Mar 11, 2006Paper

Intravesical BCG instillations for the treatment of superficial bladder tumours in renal transplant recipients

Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
Yann NeuzilletEric Lechevallier

Abstract

Superficial urothelial tumours of the bladder are more frequent and more often at higher risk of progression and recurrence in renal transplant recipients. When conservative treatment of these tumours is indicated, BCG instillations are recommended. However, immunosuppression of renal transplant recipients constitutes a classical contraindication to BCG therapy. Some authors have nevertheless used BCG instillations in renal transplant recipients. The authors reviewed the use of BCG in renal transplant recipients by studying the effects of immunosuppression on the mechanisms of action of BCG and the various clinical experiences reported in the international literature.

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Related Papers

Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
F SaintD K Chopin
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
Thierry Lebret
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
D K Chopin
© 2021 Meta ULC. All rights reserved